64x Bio
Enabling next generation medicines. A comprehensive platform and…
About
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.
Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 25 employees
- YC batch
- Summer 2018
- Status
- Active
- Stage
- Early stage
